Find Academic Supervisors

Jinhu Li is a Senior Research Fellow at the Australian National University, holding positions in both the Department of Health Economics, Wellbeing and Society and the National Centre for Health Workforce Studies. She has previously held academic positions as a Senior Lecturer at Deakin University and a Senior Research Fellow at the University of Melbourne. Dr. Li completed her PhD in Economics from McMaster University in Canada, following an MA in Economics from the University of Victoria and a BA in Economics from Huazhong University of Science and Technology in China. She is also a Fellow of the UK Higher Education Academy (HEA). Her research focuses on health economics, economics of education, and development economics, with particular emphasis on social determinants of health, human capital formation, and health workforce economics. Dr. Li employs advanced methodologies including causal inference techniques and Discrete Choice Experiments to investigate critical issues in health, education, and development. Her recent publications span topics including the impacts of education on health outcomes, physician behavior and incentives, early-life health shocks, and child malnutrition. Her work appears in leading journals such as Journal of Health Economics, Journal of Development Economics, Health Economics, and Social Science and Medicine. Dr. Li has received significant recognition for her research, including an Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA) from 2017-2023. She has secured over $4.2 million in research funding, with $3.8 million from Category 1 national competitive grants. She currently leads multiple major research projects, including an ARC DECRA project, an ARC Discovery Project, and an MRFF Primary Health Care Research grant. Her current research examines the impacts of counter-COVID public policies like school closures on child development and optimal workforce mix for team-based care in managing chronic diseases.

• Health Economics
• Economics of Education
• Development Economics
• +3 more

Tracey-Lea Laba is an Adjunct Associate Professor at the Centre for Health Economics Research and Evaluation (CHERE) within the Faculty of Health at the University of Technology Sydney. As an NHMRC Early Career (Sidney Sax) Fellow and registered pharmacist, she brings extensive clinical experience to her academic work. Her research portfolio spans health economics, pharmacoepidemiology, medication utilization, and health policy with a focus on improving health outcomes for disadvantaged populations through better use of high-value medicines for non-communicable diseases. Dr. Laba received her PhD from The University of Sydney in 2014 and was a University Medallist for her Bachelor of Pharmacy (2004). Prior to joining UTS, she held positions as a senior research fellow at The George Institute for Global Health and the Menzies Centre for Health Policy, and completed an honorary postdoctoral fellowship at The University of British Columbia. Her clinical background includes hospital and community pharmacy practice as well as pharmaceutical industry experience. Her research interests focus on health economics, drug utilization and policy, clinical trial translation, and improving medication access for non-communicable diseases. Dr. Laba has secured significant funding for projects including the Centre of Research Excellence in Medicines Intelligence (2020-2025), the ORIENT study on rural access to reproductive health services (2020-2026), and research on medication utilization patterns in cancer care and cardiovascular disease management. An analysis of her recent publications reveals a consistent focus on practical healthcare implementation challenges, with particular attention to medication access, quality improvement in primary care, and health system strengthening. Her work spans both Australian healthcare contexts and global health applications, particularly in low-resource settings in South Asia. Among her notable professional recognitions, Dr. Laba is the first health economist elected to Asthma Australia's Professional Advisory Council and the first person outside the PBAC chair to serve on both the drug utilization and economics subcommittees of the Pharmaceutical Benefits Advisory Committee. Dr. Laba actively supervises Masters and PhD students and has received funding through the NHMRC Early Career Fellowship program. Her research has been supported by multiple grants from the Medical Research Future Fund and NHMRC totaling millions of dollars across various projects focused on medicines intelligence, rural healthcare access, and global health interventions.

• Health Economics
• Pharmacoepidemiology
• Medication Utilization
• +6 more

Professor Ian Scott is a Professorial Research Fellow in the Centre for Health Services Research at The University of Queensland’s Faculty of Health, Medicine and Behavioural Sciences, and Director of Internal Medicine and Clinical Epidemiology at Princess Alexandra Hospital. He is a consultant general physician with expertise in health services evaluation, clinical guidelines, evidence-based medicine, and AI-driven clinical decision-making. His research focuses on low-value care reduction, deprescribing protocols, diagnostic safety, and AI implementation in healthcare. Education: Masters (Health Administration, UNSW); Masters (Education, UQ); Royal Australasian College of Physicians qualifications. Leadership Roles: Inaugural Chair of the Australian Deprescribing Network, Queensland Clinical Networks Executive, and founding member of ANZA-SIDM. Grants: NHMRC Partnership Projects, MRFF grants, and others totaling over 300+ publications. Research Highlights: Pioneered the CEASE deprescribing protocol, led sepsis AI working groups, and improved hospital emergency department efficiency through quality reforms. His work on machine learning for drug dosing and diagnostic error mitigation has global impact. Grants and Funding: Current grants include RELEASE+ (antidepressant deprescribing) and REMAIN HOME 2.0 (medication handover optimization).

• Clinical Decision Making
• Low Value Care
• Advance Care Planning
• +3 more

Professor Karen Soldatic is a leading academic in the School of Social Sciences at Western Sydney University, specializing in disability studies, social justice, and intersectional analysis. Her work critically examines the intersections of disability, migration, Indigenous rights, and digital technology within Global South contexts. Her research interests focus on Disability Studies , Social Justice , Artificial Intelligence and Disability , Indigenous Rights , and Migration Studies . Through participatory methodologies, she investigates how digital systems, welfare policies, and social structures create barriers for marginalized communities, particularly women with disabilities in low-income countries and Indigenous populations in Australia. Analysis of her recent publications reveals a strong emphasis on technology-facilitated violence against women with disabilities , digital inclusion frameworks , and intersectional resistance strategies . Her work consistently bridges academic theory with community action, focusing on practical interventions for systemic change. Professor Soldatic has secured significant research funding through projects including Walking my path: NSW Indigenous LGBTIQ+ peoples' experiences & aspirations (2023-2027) and Environmental Stewardship Resurgence in Walbanga Land . Her community engagement includes membership in the Australian Sociological Association and Diversty Arts Australia. Her academic contributions include 181 research outputs, 14 major projects, and active supervision of HDR candidates. She holds a PhD from the University of Western Australia and maintains strong connections with disability advocacy organizations including the Australian Federation of Disability Organisations.

• Disability Studies
• Social Justice
• Artificial Intelligence and Disability
• +5 more

Emily Callander is a Professor of Women’s Health Economics at the Monash Centre for Health Research and Implementation, Monash University, and Head of Discipline in Health Services Management at the University of Technology Sydney (UTS). She leads the Women’s Economics and Value Based Care research program and holds leadership roles in national health policy, including as Vice President of Women's Healthcare Australasia and member of the Pharmaceutical Benefits Advisory Committee Economics Subcommittee. BA in Economics and Policy, Griffith University PhD in Health Economics, University of Sydney Postdoctoral training at NHMRC Clinical Trials Centre and Charles Perkins Centre, University of Sydney Her research focuses on maternal and women's health, utilizing linked administrative data, economic evaluation, and modelled analysis to influence health policy and delivery. Her work spans efficient staffing models, rural health access, national maternity initiatives (e.g., Safer Baby Bundle, Normal Birth Strategy), and cost analyses for global maternal health programs supported by the Gates Foundation. Her recent publications reflect a strong trend in health economic evaluations of maternity care models, medication use in pregnancy, digital health implementation, and preterm birth prevention. These works emphasize real-world applicability, equity, and cost-effectiveness, aligning with her mission to embed economic evidence into health systems. She has been supported by prestigious NHMRC awards, including a Doctoral Scholarship, Early Career Fellowship, and Career Development Fellowship. Her scientific contributions are recognized through active research projects and expert media commentary on maternity care policy. NHMRC Doctoral Scholarship NHMRC Early Career Fellowship NHMRC Career Development Fellowship Emily Callander advises on multiple national and international research projects, often as Chief or Associate Investigator, and collaborates with institutions such as Coventry University. She is actively accepting PhD students and contributes to policy through advisory roles in government and non-profit organizations. Her research is supported by grants from NHMRC, government departments, and international foundations. She leads the Women’s Economics and Value Based Care program at Monash and is a key member of the Transforming Maternity Care Collaborative. Her work is embedded in real-world health systems, partnering with consumers, providers, and policymakers to improve women’s health outcomes globally.

• Health Economics
• Women's Health
• Maternal Health
• +11 more

Susan Freeman is a Professor of International Business at the Business School of the University of South Australia (UniSA). She is actively involved in research and supervision within the UniSA Business academic unit, with a strong focus on international entrepreneurship, SME internationalization, and global strategy. Her work frequently appears in top-tier journals such as International Business Review , Global Strategy Journal , and Scandinavian Journal of Management . Her research interests span a broad range of topics including international business strategies, subsidiary autonomy in multinational enterprises, value creation in global value chains, high-performance work systems, and the dynamics of social networks in firm internationalization. She has contributed significantly to the understanding of how SMEs from diverse contexts—such as Brazil, India, and Australia—navigate international markets and develop competitive strategies. The recent publications of Professor Freeman reflect a strong trend toward conceptual and systematic reviews that integrate theoretical frameworks like the attention-based view, resource-based view, and dynamic capabilities. Her work often explores paradoxes and tensions in international management, such as coopetition at the supranational level and the balance between autonomy and control in multinational subsidiaries. She also contributes to policy-relevant research, particularly in how governments can better support foreign subsidiaries through after-care services and tailored investment promotion. Internationalization through social networks: a systematic review and future research agenda (2024) Paradoxical tensions at multiple levels: a model of unbalanced supranational coopetition (2024) High-performance work systems in public service units (2024) Are all cats grey in the dark? A new taxonomy of internationalizing SMEs (2024) Developing successful assumed autonomy-based initiatives (2023) Professor Freeman has received recognition through citations in Web of Science and Scopus, with several of her articles cited over 10 times. She has collaborated with researchers from institutions in France, Iceland, China, and the UK, indicating a strong international research network. While specific grants are mentioned in some publications (e.g., Watanabe Trust Fund, Letterstedtska Fund, HI NIAS), detailed grant histories are not fully elaborated in the provided texts. She serves as a Research Degree Supervisor at UniSA and has contributed to edited volumes and book chapters on SME internationalization and growth frontiers in international business. Her work bridges academic theory with practical implications for managers and policymakers, particularly in the areas of export strategy, organizational design in MNEs, and support mechanisms for growing firms.

• International Business
• International Entrepreneurship
• SME Internationalization
• +8 more

Professor Richard De Abreu Lourenco is affiliated with the University of Technology Sydney (UTS) as a faculty member in the Faculty of Health , specifically within the Centre for Health Economics Research and Evaluation (CHERE) since 2024. Previously, he held academic roles at UTS including Associate Professor (2018-2023), Senior Research Fellow (2016-2018), and Research Fellow (2013-2016). His non-academic career includes leadership roles at Covance (2006-2013) and Novartis Pharmaceuticals (2001-2006). Education: PhD, University of Technology Sydney (2017) Master of Economics, University of Sydney (1997) Bachelor of Economics, Murdoch University (1992) Research Focus: His work spans applied economic evaluations , specialty health economics (particularly oncology/haematology ), patient preference modeling , and priority setting in healthcare . He explores cost-effectiveness of emerging therapies (CAR-T, SABR radiotherapy), health technology assessment (HTA) , and value frameworks for high-cost treatments . Recent Trends: Recent publications analyze access pathways for rare disease drugs , methodological challenges in discrete choice experiments , cost-effectiveness of radiotherapy vs. ablation , and genetic risk stratification in endocrine tumors . Collaborative work spans oncology , public health policy , and diagnostic testing preferences . Supervision & Grants: Available for Masters and PhD supervision . Leads funded research projects including generative AI in pharmaceutical evaluation , digital health for culturally diverse prostate cancer patients , and economic frameworks for high-cost therapies . Collaborates with institutions like Novartis , Covance , and Cancer Australia .

• Applied Economics
• Public Health
• Health Economics
• +5 more

Associate Professor Brendan Mulhern (University of Technology Sydney) is a health economist and outcomes researcher at the Centre for Health Economics Research and Evaluation (CHERE). He leads the Cancer Australia-funded Cancer Quality of Life Expert Support Team (CQUEST) and joined UTS in 2015, completing his PhD in 2020. BSc (Hons) Psychology, University of Wolverhampton (UK) MRes Psychology, University of Birmingham (UK) PhD Health Economics, University of Technology Sydney (Australia) His research focuses on developing and validating preference-based quality-of-life measures (EQ-5D, SF-6D) using advanced psychometric techniques like item response theory and discrete choice experiments. He specializes in condition-specific instruments for dementia, epilepsy, and diabetes, and has contributed to valuation methods including time trade-off approaches. His recent work examines context effects in palliative care valuation, cross-cultural value set development (e.g., Ghana), and improving respondent engagement in DCE studies. Key projects include: Developing the EQ-5D-5L Ghanaian value set Testing EQ-5D respiratory bolt-ons in Australia Extending QALY framework through instrument combination Validating care recipient burden scales He has received grants from EuroQol Research Foundation, Cancer Australia, and MRFF for methodological advancements in quality-of-life measurement. His work informs health technology assessment and resource allocation decisions globally.

• Health Economics
• Outcomes Research
• Quality of Life Assessment
• +4 more

Professor Kirsten McCaffery is an NHMRC Principal Research Fellow and Director of the Sydney Health Literacy Lab at the School of Public Health, University of Sydney . She leads research in health communication, shared decision-making, and health literacy, focusing on socially disadvantaged populations including culturally and linguistically diverse (CALD) communities. Her work addresses critical gaps in cancer screening, overdiagnosis, and low-value healthcare practices. Key Affiliations: Director of Research, School of Public Health; Director, Sydney Health Literacy Lab; Co-founder, Wiser Healthcare; Node Leader, Charles Perkins Centre Health Literacy Node Research Themes: Obesity, Diabetes and Cardiovascular Disease; Cancer; Healthy Ageing Research Methodology: Combines quantitative methods (randomised trials, experimental studies) and qualitative research to evaluate decision aids, health literacy interventions, and communication strategies during health emergencies like the COVID-19 pandemic. Scientific Awards: 2023 Research.com Social Sciences and Humanities in Australia Leader Award 2022 SHaPED Trial of the Year Award 2021 Public Health Research & Practice Best Paper 2020 Fellow of the Australian Academy of Health and Medical Sciences Leadership & Impact: Director of a 35-member research group, co-founder of a cross-institutional collaboration (Wiser Healthcare), and principal investigator on AU$57m+ in competitive grants. Her work has been published in Lancet, BMJ, JAMA, and MJA , with over 350 publications.

• Shared Decision Making
• Health Literacy
• Psychosocial Outcomes
• +11 more

Associate Professor Jason Bendall is a conjoint academic at the University of Newcastle's School of Medicine and Public Health, specializing in Anaesthesia and Intensive Care. As Clinical Dean at the Manning Clinical School within the Department of Rural Health, he bridges clinical practice with medical education. His career spans paramedicine, clinical epidemiology, and emergency care research. Undergraduate: Honours in Medical Science (1991) Medical Degree & PhD in Medicine (2004) Postgraduate: Clinical Epidemiology and Biostatistics Research spans paramedicine , prehospital medicine , and clinical anaesthesia with a focus on resuscitation, trauma systems, and acute pain management. Recent work includes tourniquet use analysis, back pain management strategies, and airway registry insights. Key trends in publications: prehospital trauma systems evaluation (2023-2025), airway management improvements (2022-2024), seizure pharmacology (2024), and back pain utilization studies (2024). His research combines clinical trials with large-scale data linkage projects. Professional roles include: Staff Specialist in Anaesthesia at John Hunter Hospital (2018–present) Commissioner at St John Ambulance Australia (2016–present) Convenor of Australian Resuscitation Council's First Aid Subcommittee ILCOR First Aid Task Force Member His work with the Out-of-Hospital Airway Registry and ambulance trauma protocols demonstrates commitment to improving emergency medical systems through evidence-based governance and clinical innovation.

• Paramedicine
• Prehospital and Retrieval Medicine
• Clinical Anaesthesia
• +6 more

Dr Stephanie Mathieson is a Senior Research Fellow at Sydney Musculoskeletal Health, a flagship research group within the University of Sydney’s Faculty of Medicine and Health. She is based at the Kolling Institute at Royal North Shore Hospital. Her work focuses on reducing low-value care for musculoskeletal conditions, particularly spinal pain and sciatica, and has influenced over 11 international clinical guidelines. She holds an NHMRC Early Career Fellowship (2019–2022) and has contributed to studies on opioid deprescribing, gabapentinoid use, and healthcare policy. Education: PhD. She supervises Higher Degree Research students, including Justin Cheng (Evidence-based guideline for deprescribing gabapentinoids) and Charlotte Johnstone (Pain and pelvic exenteration surgery outcomes). Research Interests: Reducing inappropriate pharmacological treatments for musculoskeletal conditions Opioid and gabapentinoid deprescribing strategies Clinical guideline development and implementation Health literacy and patient beliefs in pain management Systematic reviews and meta-analyses Health policy and healthcare expenditure Scientific Contributions: Over 30 peer-reviewed articles in leading journals like the New England Journal of Medicine, BMJ, and Annals of Internal Medicine. Her research spans behavioral nudging interventions, infodemiology studies on social media, and guideline adherence mechanisms. Awards and Grants: NHMRC Early Career Fellowship (2019–2022), FMH Showcase Travel Award 2023, and participation in multiple funded projects including the 2023 Restructuring Musculoskeletal Health Services grant. Professional Engagement: Serves on committees for the Australian Pain Society, ANMUSC Network, and ACI Musculoskeletal Network. Active in national/international conferences and co-developed the BacKS survey tool to assess patient knowledge about low back pain. Future Work: Expanding deprescribing research into other medications, investigating virtual care models, and enhancing primary care pain management strategies through guideline implementation.

• Pain Management
• Musculoskeletal Health
• Deprescribing
• +6 more

Laura Hemmings is a Senior Lecturer in the Department of Health Professions at Macquarie University. She specializes in developmental paediatrics, focusing on interventions and outcomes for children born extremely preterm or with low birth weight. Her clinical expertise includes paediatric and neonatal intensive care. Education: PhD in Physiotherapy from The University of Queensland, SFHEA (Senior Fellowship of the Higher Education Academy awarded 2021). Research Interests: Neonatal intensive care, paediatric pain management, motor control screening tools, and neurological assessments. Her work emphasizes clinical validation of tools for early developmental delays and pain assessment in infants. Key Achievements: Received the 2022 Vice-Chancellor’s Award for Learning Innovation (Highly Commended Finalist) for collaborative educational initiatives. Notable Activities: Presented on preterm physiotherapy interventions at conferences, including a 2017 presentation on pre-prep interventions for preterm children.

• Developmental Paediatrics
• Neonatal Intensive Care
• Paediatric Physiotherapy
• +3 more

Dr Sundresan Naicker is a Research Fellow in Implementation Science at the School of Public Health & Social Work, Faculty of Health, Queensland University of Technology (QUT). His research focuses on health services and systems, particularly examining healthcare technology adoption, implementation science, and improving healthcare delivery efficiency. He holds a PhD from the University of Sydney and has published extensively on topics including clinical decision support systems, patient non-attendance costs, and shared care models. Education: Doctor of Philosophy (University of Sydney) His research interests span health informatics, clinical workflow optimization, and qualitative studies on healthcare provider dynamics. Notable publications explore the impact of the COVID-19 pandemic on clinician-IT interactions, cost analyses of non-attendance in physiotherapy, and strategies to reduce low-value care in hospital settings. Naicker has received awards including the RACGP Foundation Grant (2021) and a federal Research & Development grant (2018). He currently supervises two PhD candidates focusing on healthcare service evaluation and workforce factors in oral healthcare. His work bridges implementation science and real-world healthcare challenges, emphasizing stakeholder collaboration and evidence-based solutions to improve patient outcomes and system efficiency.

• Health services and systems
• Public Health
• Healthcare Management
• +4 more

Dr. Loai Albarqouni is an NHMRC Emerging Leader Fellow and Assistant Professor at Bond University's Faculty of Health Sciences & Medicine, affiliated with the Institute for Evidence-Based Healthcare. He holds an MD from Al-Quds University, an MSc in Clinical Epidemiology from Ludwig Maximilian University of Munich, and a PhD in Evidence-Based Practice from Bond University. His research focuses on evidence-informed decision-making, non-drug interventions, and addressing overdiagnosis and overuse of healthcare services in limited-resource settings. Dr. Albarqouni's expertise spans clinical epidemiology, evidence synthesis, shared decision-making frameworks, and public health strategies. He has contributed to studies on dietary interventions for mental health, generative AI in evidence synthesis, and optimizing healthcare delivery post-pandemic. His work emphasizes improving healthcare efficiency and reducing low-value medical practices globally. Key scientific contributions include systematic reviews on salt substitution for cardiovascular outcomes, Mediterranean diet efficacy, and barriers to non-drug interventions in primary care. He has also explored the impact of timing for meals and fasting strategies on metabolic health. Awarded the NHMRC Emerging Leader Fellowship, his research aligns with UN Sustainable Development Goals related to health equity and quality education. Dr. Albarqouni actively participates in academic activities like organizing systematic review workshops and collaborates internationally on evidence-based practice initiatives.

• Clinical Epidemiology
• Evidence Synthesis
• Shared Decision Making
• +5 more

Professor Anne Souvertjis serves as a Professor of Marketing and founding member of the Ehrenberg-Bass Institute, functioning as a Senior Marketing Scientist with over 50 academic publications. Her work bridges marketing science and sustainability through industry-partnered research collaborations with government bodies, regulators, and commercial entities. Her research centers on sustainable consumer behavior, with core focus areas including: Impact of retail plastic bag bans on anti-consumption behavior Household waste and recycling patterns Food waste prevention strategies Development of waste avoidance metrics Sharing economy dynamics (buying avoidance) Carbon labeling effects on grocery choices Recent publications reveal strong interdisciplinary trends combining environmental science, behavioral psychology, and retail strategy. Her work frequently addresses sustainability measurement challenges, appearing in top-tier journals like the European Journal of Marketing and International Journal of Research in Marketing, with increasing emphasis on policy-relevant consumer behavior insights. Professor Souvertjis teaches Market Research at undergraduate and postgraduate levels while serving as University ethics chair. Her industry-partnered research model generates practical applications through direct collaboration with governmental agencies, regulatory bodies, and commercial organizations seeking sustainable market solutions. As a founding member of the Ehrenberg-Bass Institute—the world's largest marketing research center with over 60 scientists—she contributes to large-scale behavioral studies on shopper patterns, waste reduction, and sustainable consumption, leveraging the institute's unique access to real-world retail environments and consumer data.

• Sustainable Marketing
• Consumer Behaviour
• Environmental Sustainability
• +3 more